🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
Study Aims 1. To measure the clinic response rates in patients with breast...
Status
Completed
Location
Chao Family Comprehensive Cancer Center
Start Date
2005-10
Trial ID
NCT00254592
Treatments Being Tested
Dose dense chemotherapy, which is the term for Adriamycin and Cyclophospham...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-10
Trial ID
NCT00546156
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, c...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2008-05-02
Trial ID
NCT00679029
This is a phase IIb, randomized, parallel-group, noncomparative, multicente...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-08
Trial ID
NCT00365365
In the MDACC/BrUOG neoadjuvant trial with weekly paclitaxel followed by Flu...
Status
Completed
Location
Bridgeport Hospital
Start Date
2008-09
Trial ID
NCT00723125
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Start Date
2006-11
Trial ID
NCT00408408
This randomized phase II trial studies how well paclitaxel with or without ...
Status
Completed
Location
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Start Date
2009-07-21
Trial ID
NCT00861705
The primary objective of this study was to compare the safety of dose-dense...
Status
Completed
Location
Multiple Locations
Start Date
2006-08-01
Trial ID
NCT00394251
Treatments Being Tested